Is Avricore Health Inc. (AVCR.V) a Buy, Sell, or Hold?
Avricore Health Inc.
TSXV:AVCR.V
$0.07 CAD
$0.01 (27.27%)
- Volume
- 660.8K
- Average Volume
- 208.66K
- Market Capitalization
- $7.09M
- P/E Ratio
- -2395.00
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $0.34
- Year Low
- $0.05
- Payout Ratio
- $0.00
- Current Ratio
- $2.79
Industry, Sector & symbol
| Stock Exchange | Toronto Stock Exchange Ventures |
| CEO | Mr. Hector Bremner |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | AVCR.V |
| CUSIP | None |
| CIK | None |
| Web | https://www.avricorehealth.com |
| Phone | 604-773-8943 |
| Currency | CAD |
| Employees | None |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.79 |
| Quick Ratio | 2.76 |
| Cash Ratio | 1.63 |
Sales & Book Value
| Annual Sales | $3.49M |
| Price / Sales | 1.58 |
| Cash Flow | 0.00 |
| Price / Cash Flow | 73.37 |
| Price / Book | 3.07 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.007 |
| Trailing P/E Ratio | -2395.00 |
| PEG Ratio | -24.65 |
| P/E Growth | -24.65 |
| Net Income | $-701.22K |
| Net Margin | -0.07% |
| Pretax Margin | -0.07% |
| Return on Equity | -0.14% |
| Return on Assets | -0.11% |
Financials Score
| AltmanZ Score | -2.39 |
| Piotroski Score | 4.00 |
| Working Capital | 609.11K |
| Total Assets | 2.62M |
| Ebit | -2.23K |
| Market Cap | 7.09M |
| Total Liabilities | 341.18K |
Poll Results
About Avricore Health Inc. (TSXV:AVCR.V) Stock
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a lab-accurate point of care testing platform for pharmacy. The company has strategic partnerships with Shoppers Drug Marts and Abbott. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current Avricore Health Inc. (AVCR.V) stock price?
-
Avricore Health Inc.(TSXV:AVCR.V) stock price is $0.07 in the last trading session. During the trading session, AVCR.V stock reached the peak price of $0.335 while $0.05 was the lowest point it dropped to. The percentage change in AVCR.V stock occurred in the recent session was 27.27% while the dollar amount for the price change in AVCR.V stock was $0.01.
-
AVCR.V's industry and sector of operation?
-
The TSXV listed AVCR.V is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of AVCR.V?
-
Mr. Rodger Seccombe | Chief Technology Officer & Director
Ms. Kiriaki Smith CPA, CFO, CGA, CPA | Chief Financial Officer & Corporate Secretary
Mr. Will Seccombe | Communications Advisor
Mr. Hector Bremner | Chief Executive Officer & Director
| -
How many employees does AVCR.V have?
-
Number of AVCR.V employees currently stands at None. AVCR.V operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.
-
Link for AVCR.V official website?
-
Official Website of AVCR.V is: https://www.avricorehealth.com
-
How do I contact AVCR.V?
-
AVCR.V could be contacted at phone #604-773-8943 and can also be accessed through its website. AVCR.V operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.
-
How many shares of AVCR.V are traded daily?
-
The average number of AVCR.V shares traded daily for last 3 months was 208.66K.
-
What is the market cap of AVCR.V currently?
-
The market value of AVCR.V currently stands at $7.09M with its latest stock price at $0.07